Levoketoconazole: a novel treatment for endogenous Cushing's syndrome

Taylor and Francis Group, Expert Review of Endocrinology and Metabolism, 4(16), p. 159-174, 2021

Journal article published in 2021 by Maria Fleseriu

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by